| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.448 | 26.666 | - | 20.333 | - | 15.527 | 39.934 | 38.772 | 39.494 | 39.179 |
| Total Income - EUR | 3.448 | 26.666 | - | 20.333 | - | 15.527 | 39.934 | 38.772 | 39.494 | 39.179 |
| Total Expenses - EUR | 3.013 | 12.881 | - | 20.487 | - | 11.974 | 14.204 | 23.967 | 28.728 | 32.234 |
| Gross Profit/Loss - EUR | 435 | 13.786 | - | -155 | - | 3.554 | 25.730 | 14.805 | 10.766 | 6.945 |
| Net Profit/Loss - EUR | 332 | 13.149 | - | -358 | - | 3.522 | 25.331 | 14.442 | 10.370 | 5.729 |
| Employees | 1 | 1 | - | 0 | - | 2 | 2 | 2 | 0 | 2 |
Check the financial reports for the company - Fil Ştefmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | - | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 4.364 | 17.541 | - | 10.978 | - | 15.745 | 41.140 | 55.702 | 66.851 | 72.816 |
| Inventories | 124 | 122 | - | 336 | - | 324 | 316 | 317 | 316 | 315 |
| Receivables | 2.867 | 2.838 | - | 10.410 | - | 10.412 | 2.861 | 2.870 | 2.862 | 2.846 |
| Cash | 1.373 | 14.581 | - | 231 | - | 5.010 | 37.962 | 52.514 | 63.673 | 69.656 |
| Shareholders Funds | -155 | 12.995 | - | 9.706 | - | 15.273 | 40.265 | 54.832 | 65.037 | 70.402 |
| Social Capital | 45 | 0 | - | 43 | - | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.520 | 4.546 | - | 1.272 | - | 472 | 875 | 869 | 1.814 | 2.414 |
| Income in Advance | 0 | 0 | - | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Fil Ştefmed Srl